MITUXA SMALL CAPS PORTFOLIO1 BUY · 9 WAIT · every decision explained.See the decisions ↗

Independent investment research

Small companies.
Serious research.

MITUXA looks beyond the obvious names to find specialised businesses with room to compound — then separates business quality from an investable price.

01 / WHY SMALL CAPS

The opportunity is not that small companies are automatically better. It is that fewer investors do the work.

Less coverage can create larger gaps between price and business reality. We focus on understandable economics, defensible niches, financial quality and management that can reinvest without destroying value.

02 / THE INAUGURAL TEN

A global research universe—with decisions.

Only BUY receives capital.
WAIT remains in cash.

01WAIT

Industrial connectivity

HMS Networks

HMS · Nasdaq StockholmValuation · €1,000 reserved
02WAIT

Surgical quality assurance

Medistim

MEDI · Oslo BørsValuation · €1,000 reserved
03WAIT

Measurement intelligence

Vaisala

VAIAS · Nasdaq HelsinkiValuation · €1,000 reserved
04WAIT

Advanced electronics manufacturing

Kitron

KIT · Oslo BørsRisk-adjusted valuation · €1,000 reserved
05WAIT

Power and connectivity

Bel Fuse

BELFB · NasdaqValuation · €1,000 reserved
06WAIT

Mining technology

Chrysos Corporation

C79 · ASXEarnings maturity · €1,000 reserved
07WAIT

Specialist electronics

discoverIE Group

DSCV · London Stock ExchangeMargin of safety · €1,000 reserved
08BUY

Electrification infrastructure

IPD Group

IPG · ASXAll gates passed · €1,000 allocated
09WAIT

Digital diagnostics

CellaVision

CEVI · Nasdaq StockholmGrowth / valuation · €1,000 reserved
10WAIT

Precision automation

Kendrion

KENDR · Euronext AmsterdamQuality confirmation · €1,000 reserved

03 / FUNDAMENTAL

MITUXA
Fundamental.

Long-term investment decisions based on business quality, financial strength, competitive advantage and valuation. Momentum never changes a fundamental BUY or WAIT decision.

3–5 year horizon · Updated 28 August 2026
LONG-TERM BUY8Quality and price pass
WATCHLIST63Wait for price or evidence
HOLD1Existing positions
REVIEW11Thesis under review

ACTIVE FUNDAMENTAL BUYS

Business quality at the right price.

APPNVOALNYHUBSMNDYNBIXPEGAPINS
Open Fundamental decisions

04 / MOMENTUM

MITUXA
Momentum 5.

A separate quarterly portfolio of five liquid market leaders selected through relative strength, quality, trend and disciplined risk. This is not the Fundamental list.

Launches 1 October 2026 · five public selections
01

Public selection

NEXT

Revealed 1 October

Free inaugural portfolio
02

Public selection

NEXT

Revealed 1 October

Free inaugural portfolio
03

Public selection

NEXT

Revealed 1 October

Free inaugural portfolio
04

Public selection

NEXT

Revealed 1 October

Free inaugural portfolio
05

Public selection

NEXT

Revealed 1 October

Free inaugural portfolio

QUARTERLY SCORECARD

Every result.
Explained.

  • 01Portfolio returnQuarter and since launch
  • 02Market comparisonPerformance versus benchmark
  • 03Winners & lossesWhat worked and what failed
  • 04Next decisionHold, replace or remove

05 / LIVE EXPERIMENT

Experimental · Quarter 01

One Quarter.
Experimental.

A $10,000 portfolio. Five undisclosed US equities. Three months to test whether a disciplined selection process can beat passive exposure.

No names during the experiment. No hindsight. The result will be reported whether positive or negative.

Starting capital$10,000
Positions5
Allocation$2,000 each
Period25 Jul — 25 Oct 2026
Stock 01

UNDISCLOSED

••••

$2,000 starting allocation
Stock 02

UNDISCLOSED

••••

$2,000 starting allocation
Stock 03

UNDISCLOSED

••••

$2,000 starting allocation
Stock 04

UNDISCLOSED

••••

$2,000 starting allocation
Stock 05

UNDISCLOSED

••••

$2,000 starting allocation

DAILY SCORECARD

Updated after every US market close.

Current value$10,115.59US market closed
Total return+1.16%As of 28 August 2026

Individual holdings and entry prices remain private. Only the aggregate portfolio value and return are published, with one update per market day.

06 / THE DISCIPLINE

Small-cap research without small-cap excuses.

01

Understand the mechanism

What problem does the company solve, why does the customer care and where does the economic value accrue?

02

Test the moat

Niche leadership only matters when it creates pricing power, switching costs, recurring demand or superior returns.

03

Follow the cash

Growth must convert into operating profit, free cash flow and productive reinvestment — not permanent dilution.

04

Pay the right price

A compelling company is not automatically a compelling investment. Valuation remains part of the thesis.

07 / EVERGREEN RESEARCH

The archive stays. The focus becomes sharper.

Deep research on businesses
of every size.

View the complete research archive ↗

08 / OPEN THROUGH 2026

Build trust first.

MITUXA research remains open through 31 December 2026. The public record — including Fundamental, Momentum and the Small Caps Portfolio — is part of the product, not a marketing claim.

Join the research free